在非缺血扩大心肌病中,左心室卸载改善了冠状动脉血液动力储备
Samer Fawaz1,2, Rohini Ramaseshan3,4, Sarosh Khan1,2
1The Essex Cardiothoracic Centre, Basildon Hospital, Basildon, UK.
概括
使用Impella CP装置进行皮肤室内卸载 (PVU) 显著改善了扩张性心肌病患者的冠状动脉流量储备 (CFR) 和微血管阻力储备 (MRR). 这些发现表明,在Impella CP支持后,冠状动力学功能得到了增强.
科学领域:
- 心脏病学 心脏病学
- 心血管器械 心血管器械
- 血液动力学 血液动力学
背景情况:
- 伊佩拉CP是一种以导管为基础的腹腔辅助装置,用于心脏性休克和高风险皮肤冠状动脉干预 (PCI).
- 需要进一步量化Impella CP对冠状动脉流动力学的影响,通过冠状动脉内连续热稀释进行测量.
研究的目的:
- 评估使用Impella CP进行皮肤穿室卸载 (PVU) 对冠状动脉流量储备 (CFR) 和微血管阻力储备 (MRR) 的影响.
- 为了评估这些血液动力学参数,在接受自主骨髓衍生单核细胞 (BMMNC) 输液的严重非缺血性扩张性心肌病患者中.
主要方法:
- 冠状动脉流量 (Q) 用静止 (Qrest) 和高血压 (Qhyper) 期间的冠状动脉连续热稀释进行测量.
- 在使用Impella CP之前和之后,在左前下降动脉 (LAD) 中进行测量,使用专门的压力/热敏仪冠状动脉导线.
- 冠状动脉流量储备 (CFR) 和微血管阻力储备 (MRR) 在术后进行计算.
主要成果:
- 使用Impella CP启动LV卸载导致CFR (2.72至3.9,p=0.049) 和MRR (3.09至4.50,p=0.022) 显著增加.
- 在PVU后观察到平均Qrest的减少和平均Qhyper的增加.
结论:
- 使用Impella CP进行皮肤腔室卸载显著增加了冠状动力学储备,由增加的CFR和MRR表明.
- 需要在更大的患者队伍中进行进一步的验证,以确认这些血液动力学改善.
更多相关视频
05:07Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
981
06:39Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
Published on: April 13, 2015
14.9K
相关概念视频
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:22Heart Failure Drugs: β-Blockers
322
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
322